What is semaglutide?
Semaglutide mimics the activity of GLP-1, a naturally occurring hormone involved in appetite, digestion and blood-sugar regulation. Prescription semaglutide is available in different branded medicines and formulations depending on the indication and market.
Why people find it useful
For people who are clinically suitable, semaglutide can reduce appetite, help people feel fuller for longer and improve glucose regulation. Large clinical programmes have also shown meaningful weight reduction in many people with obesity or overweight when treatment is combined with appropriate lifestyle support.
Some semaglutide products also have approved cardiovascular-risk-reduction indications for certain adults with established cardiovascular disease and obesity or overweight. The exact approved uses depend on the specific product and country.
What people commonly track
A consistent record can make a routine easier to understand. People may choose to track scheduled administrations, weight trends, hydration, general wellbeing, symptoms and remaining supply. AEVLI is designed to organise those records without using private tracking data to select commercial offers.
What to keep in mind
Semaglutide can cause side effects, most commonly gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation or abdominal discomfort. Product labelling also contains important warnings and contraindications. Anyone using a prescription GLP-1 medicine should follow the instructions for their specific product and speak with their clinician or pharmacist about concerns.
Sources reviewed
This page was prepared using current public information from the NHS and U.S. FDA. AEVLI will add dated editorial review information and country-specific source references as the publishing system expands.